MediWound (MDWD) Net Equity Issued and Repurchased (2014 - 2025)

MediWound's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $28.2 million for Q3 2025.

• On a quarterly basis, Net Equity Issued and Repurchased rose 25.55% year-over-year to $28.2 million in Q3 2025; TTM through Sep 2025 was $50.6 million, a 5.77% increase from a year earlier, with the FY2024 full-year figure at $22.2 million, down 11.02% from the prior year.
• Net Equity Issued and Repurchased climbed to $28.2 million in Q3 2025 per MDWD's latest filing, from -$499000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $28.2 million in Q3 2025 and bottomed at -$556000.0 in Q2 2022.
• The 5-year median for Net Equity Issued and Repurchased is $5.5 million (2021), against an average of $10.7 million.
• Across the five-year window, Net Equity Issued and Repurchased soared 55.4% in 2023 and plunged 98.02% in 2024, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $10.4 million in 2021, then tumbled by 105.34% to -$556000.0 in 2022, then surged by 55.4% to -$248000.0 in 2023, then slumped by 101.21% to -$499000.0 in 2024, then jumped by 5745.09% to $28.2 million in 2025.
• Per Business Quant, the three latest MDWD Net Equity Issued and Repurchased figures stand at $28.2 million (Q3 2025), -$499000.0 (Q4 2024), and $22.4 million (Q3 2024).